Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the arthritic therapeutic market grown over the years?

The arthritic therapeutic market has witnessed steady expansion, expected to grow from $68.1 billion in 2024 to $72.44 billion in 2025, reflecting a 6.4% CAGR. Past growth drivers include a rising number of diagnosed cases, increased awareness of symptoms, obesity prevalence, advancements in diagnostic capabilities, and better treatment outcomes.

What Is the forecasted market size and growth rate for the arthritic therapeutic market?

The arthritic therapeutic market is expected to witness strong growth, reaching $91.72 billion by 2029 at a CAGR of 6.1%. Factors driving growth include improved healthcare infrastructure, government initiatives, favorable regulatory policies, a focus on personalized medicine, and a shift toward patient-centric healthcare. Notable trends include increased adoption of biosimilars, a shift toward biologics, preference for parenteral administration, and the expansion of online pharmacies.

Get your arthritic therapeutic market report here!

https://www.thebusinessresearchcompany.com/report/arthritic-therapeutic-global-market-report

What are the major factors driving growth in the arthritic therapeutic market?

The arthritic therapeutic market is witnessing growth due to the rising incidence of arthritis, a condition affecting joints through pain and inflammation. Contributing factors include an aging population, increased obesity rates, and lifestyle-related joint stress. Arthritis treatments improve joint function and quality of life. In June 2024, the Australian Institute of Health and Welfare reported that approximately 514,000 people (2% of the population) had rheumatoid arthritis in 2022, contributing 16% to the total musculoskeletal disease burden in 2023, driving demand for arthritic therapies.

What key areas define the segmentation of the global arthritic therapeutic Market?

The arthritic therapeuticmarket covered in this report is segmented –

1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes

2) By Route Of Administration: Oral, Parenteral, Topical

3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab

2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors, Interleukin-1 (IL-1) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors

3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam

4) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone

5) By Xanthine Oxidase Inhibitors: Allopurinol, Febuxostat

6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic DMARDs, Topical Analgesics, Opioid Pain Medications

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp

What are the top market players propelling the growth of the arthritic therapeutic industry?

Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH

What are the key trends shaping the future of the arthritic therapeutic market?

Companies in the arthritis therapeutic market are developing biosimilar monoclonal antibody-based therapies to improve treatment effectiveness and reduce costs. These therapies replicate the efficacy of original monoclonal antibodies, offering similar therapeutic benefits at a lower cost. For instance, in May 2024, Bio-Thera Solutions Ltd., a Chinese biopharmaceutical company, launched TOFIDENCE, an intravenous biosimilar monoclonal antibody formulation based on ACTEMRA. TOFIDENCE (tocilizumab-bavi) is approved for treating moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19297

What regions are dominating the arthritic therapeutic market growth?

North America was the largest region in the arthritic therapeutic market in 2024. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Glycomic Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report

Gout Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: